Supply a non-prescription medicine
Information on how to supply a non-prescription medicine.
Last updated
Latest alerts
-
Product correction: Ypsomed Australia is reminding users to ensure they use a compatible smart device and operating system (OS) when using the Mylife CamAPS FX app.
-
Phytologic Holdings Pty Ltd is recalling one batch of Henry Blooms Infant Liquid D3 & K2 with Probiotic due to a dosing syringe error.
-
We are aware of the recent report of a death of a child overseas. The death has been found to have been caused by a fire that occurred during the use of a hyperbaric chamber device.
Latest articles
-
What’s changed on the website
We have made changes to our website to make finding information easier. These improvements are based on your feedback. -
Product Information safety updates - October 2025
Information for health professionals about medicines with safety related updates to their Product Information. -
New warning on hepatotoxicity risk for Veoza (fezolinetant)
New warnings on hepatotoxicity risk and monitoring recommendations have been added to the Product Information for Veoza (fezolinetant).
Latest publications
-
Communique from the 10th meeting of the WHPWG, 17 July 2025
-
Advisory Committee on Vaccines meeting statement 53
-
Communique from the 9th meeting of the WHPWG 27 March 2025
Resources
-
This form is for sponsors to report Significant Safety Issues (SSIs) and Urgent Safety Measures (USMs) to the TGA.
-
Templates to help you with your communications under the Procedure for Recalls, Product Alerts and Product Corrections (PRAC).
-
We have adopted this International Scientific Guideline - EMA/618604/2008 Rev. 9
Latest consultations
-
Survey on digital mental health tools.
-
This consultation paper seeks feedback on proposals identified for mitigating risks and leveraging opportunities associated with the use of AI models.
-
Have your say about proposed changes to address 3 medicine safety matters needing action, before we review labelling rules more broadly.